Principal Financial Group’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-411,800
Closed -$881K 2216
2024
Q3
$881K Sell
411,800
-25,200
-6% -$54.7K ﹤0.01% 1869
2024
Q2
$817K Buy
437,000
+12,467
+3% +$32.7K ﹤0.01% 1882
2024
Q1
$1.13M Buy
424,533
+24,906
+6% +$68.9K ﹤0.01% 1852
2023
Q4
$1.23M Sell
399,627
-256,973
-39% -$610K ﹤0.01% 1813
2023
Q3
$1.04M Sell
656,600
-10,441
-2% -$20.4K ﹤0.01% 1835
2023
Q2
$1.31M Sell
667,041
-694,819
-51% -$1.33M ﹤0.01% 1806
2023
Q1
$2.63M Buy
1,361,860
+27,810
+2% +$69.6K ﹤0.01% 1716
2022
Q4
$2.8M Sell
1,334,050
-9,417
-0.7% -$21.3K ﹤0.01% 1702
2022
Q3
$3.08M Sell
1,343,467
-4,845
-0.4% -$14.7K ﹤0.01% 1639
2022
Q2
$3.82M Buy
1,348,312
+133,587
+11% +$470K ﹤0.01% 1643
2022
Q1
$5.51M Sell
1,214,725
-10,828
-0.9% -$59.6K ﹤0.01% 1630
2021
Q4
$9.95M Sell
1,225,553
-15,769
-1% -$155K 0.01% 1401
2021
Q3
$15.7M Sell
1,241,322
-21,066
-2% -$292K 0.01% 1123
2021
Q2
$19.5M Buy
+1,262,388
New +$21.2M 0.01% 994

Other funds holding CLLS

Principal Financial Group's CLLS Position: Q4 2024 in Review

Principal Financial Group sold out of Cellectis (CLLS) in Q4 2024, closing a stake of 411,800 shares — an estimated $881K sold.

Principal Financial Group first reported a position in CLLS in Q2 2021 and held it in 14 quarters. The position peaked at $19.5M in Q2 2021. 29 funds tracked by Wall St. Rank hold CLLS as of Q4 2024.

  • Principal Financial Group reported no remaining Cellectis position as of Q4 2024 after selling out during the quarter.
  • Principal Financial Group sold 411,800 Cellectis shares in Q4 2024, an estimated $881K.
  • Principal Financial Group first reported a position in Cellectis in Q2 2021 and held it in 14 quarters.
  • Principal Financial Group's Cellectis position peaked at $19.5M in Q2 2021.
  • 29 funds tracked by Wall St. Rank held Cellectis as of Q4 2024.

Based on Principal Financial Group's 13F filing for Q4 2024, filed 31 Jan 2025.